Ebastin Orifarm 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ebastin orifarm 10 mg

orifarm generics a/s - ebastin - tablett, filmdrasjert - 10 mg

Ebastin Orifarm 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ebastin orifarm 20 mg

orifarm generics a/s - ebastin - tablett, filmdrasjert - 20 mg

Kestine 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kestine 20 mg

almirall, s.a. - ebastin - tablett, filmdrasjert - 20 mg

Kestine 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kestine 10 mg

almirall, s.a. - ebastin - tablett, filmdrasjert - 10 mg

Livostin 50 mikrog/ dose নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

livostin 50 mikrog/ dose

mcneil sweden ab - levokabastinhydroklorid - nesespray, suspensjon - 50 mikrog/ dose

Livostin 0.5 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

livostin 0.5 mg/ ml

mcneil sweden ab - levokabastinhydroklorid - Øyedråper, suspensjon - 0.5 mg/ ml

Kestine 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kestine 10 mg

2care4 aps - ebastin - tablett, filmdrasjert - 10 mg

Kestine 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kestine 20 mg

2care4 aps - ebastin - tablett, filmdrasjert - 20 mg

Livostin 50 mikrog/ dose নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

livostin 50 mikrog/ dose

2care4 aps - levokabastinhydroklorid - nesespray, suspensjon - 50 mikrog/ dose

Tukysa ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.